India's Shilpa Medicare gains after over 11-fold rise in Q2 profit
** Shares of Shilpa Medicare SHME.NS rise 6.7% to 880
rupees, their biggest one-day gain since Oct. 8
** Pharma co's Q2 consol profit and revenue rises over
11-fold and 13%, respectively, helped by traction in its
emerging markets and formulation segment
** SHME sees third-busiest day in nearly three months, with
over 391,000 shares traded
** Stock extends YTD gains to 166% vs 122% gain in peer
Solara Active Pharma SOLA.NS
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees